Key Points
- Insider purchase: ConvaTec Group insider Tobias Hestler bought 50,000 shares at GBX 226 each, representing a total investment of £113,000.
- Share performance: The stock opened at GBX 232.40 and was trading 2.5% higher, with a market capitalization of approximately £4.54 billion.
- Analyst outlook: ConvaTec has a consensus “Moderate Buy” rating from analysts, with an average price target of GBX 306 compared with the reported trading price.
ConvaTec Group PLC (LON:CTEC - Get Free Report) insider Tobias Hestler purchased 50,000 shares of the stock in a transaction dated Thursday, August 6th. The stock was acquired at an average price of GBX 226 per share, for a total transaction of £113,000.
ConvaTec Group Trading Up 2.5%
Shares of CTEC opened at GBX 232.40 on Friday. The company has a debt-to-equity ratio of 121.83, a current ratio of 1.93 and a quick ratio of 0.96. The firm has a 50 day simple moving average of GBX 213.38 and a 200-day simple moving average of GBX 221.01. ConvaTec Group PLC has a 1-year low of GBX 193 and a 1-year high of GBX 259.30. The stock has a market cap of £4.54 billion, a price-to-earnings ratio of 27.02, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77.
Analysts Set New Price Targets
Several research firms have weighed in on CTEC. Royal Bank Of Canada reissued an "outperform" rating and set a GBX 315 price target on shares of ConvaTec Group in a research report on Monday, August 3rd. Peel Hunt restated an "add" rating and issued a GBX 270 price objective on shares of ConvaTec Group in a research report on Tuesday. Citigroup decreased their price objective on ConvaTec Group from GBX 250 to GBX 230 and set a "neutral" rating on the stock in a research note on Monday, May 18th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a GBX 315 price objective on shares of ConvaTec Group in a research report on Wednesday. Finally, Jefferies Financial Group reissued a "buy" rating and issued a GBX 300 target price on shares of ConvaTec Group in a research note on Wednesday. Eight analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of GBX 306.
Read Our Latest Stock Analysis on ConvaTec Group
About ConvaTec Group
(
Get Free Report)
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
